Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ) has provided an announcement.
Fisher & Paykel Healthcare has applied for quotation on the ASX of 13,569 ordinary fully paid shares, issued under an employee incentive scheme and scheduled to be quoted from 5 January 2026. The new shares, which form part of the company’s ongoing equity-based remuneration programs, will slightly increase the number of quoted securities on the ASX and support the company’s ability to attract and retain staff while maintaining its presence as a foreign exempt issuer in the Australian market.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited is a medical technology company that designs and manufactures respiratory care and acute care products, with its primary listing on the NZX and a foreign exempt listing on the ASX under the code FPH. The company focuses on hospital and home care respiratory solutions, serving global healthcare markets with devices and systems used in the treatment of patients requiring respiratory support.
See more insights into FSPKF stock on TipRanks’ Stock Analysis page.